427 related articles for article (PubMed ID: 31551254)
1. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract][Full Text] [Related]
2. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
[TBL] [Abstract][Full Text] [Related]
3. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
4. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
5. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
7. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
[TBL] [Abstract][Full Text] [Related]
8. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
10. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
Zheng X; Gai X; Wu Z; Liu Q; Yao Y
Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
[TBL] [Abstract][Full Text] [Related]
11. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
[TBL] [Abstract][Full Text] [Related]
15. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
Yang L; Chang Y; Cao P
Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
[TBL] [Abstract][Full Text] [Related]
16. The role of XBP1s in the metastasis and prognosis of hepatocellular carcinoma.
Wu S; Du R; Gao C; Kang J; Wen J; Sun T
Biochem Biophys Res Commun; 2018 Jun; 500(3):530-537. PubMed ID: 29627568
[TBL] [Abstract][Full Text] [Related]
17. T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression.
Feng X; Yao W; Zhang Z; Yuan F; Liang L; Zhou J; Liu S; Song J
Oncol Res; 2018 Jul; 26(6):959-966. PubMed ID: 29295731
[TBL] [Abstract][Full Text] [Related]
18. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
